Norris Medicines
Company Overview - January 14, 2025
Norris Medicines is a notable player in the Pharmaceuticals - Indian - Bulk Drugs & Formln industry, listed on the BSE (Code: 524414). As of the January 14, 2025, the company holds a market capitalization of INR 19.62 crores, placing it among the top-performing companies in its sector.
With a current stock price of INR 19.62, Norris Medicines has demonstrated a 49.52% return over the last year. Recent performance indicates fluctuations, with a -8.65% change in the past week and a 14.45% change over the last month. The company's all-time high stands at INR 36.75, while its lowest-ever price was INR 2.45.
In terms of sales, Norris Medicines reported a revenue of INR 4.13 crores, solidifying its position in the market. The average trading volume over the past month has been 2516 shares, with a more recent weekly average of 2114.
With the stock trading above its 50-day moving average of INR 19.25, the company's technical indicators like MACD (0.13) signal negative trends.
Company Data
| Name | Norris Medicines |
|---|---|
| BSE Code | 524414 |
| NSE Code | |
| Industry | Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Current Price | 19.62 |
| Market Capitalization | 19.62 |
| Sales | 4.13 |
| Return over 3months | 28.99 |
| Return over 6months | 52.57 |
| Volume 1month average | 2516 |
| Volume 1week average | 2114 |
| Volume | 627 |
| High price | 27.74 |
| Low price | 10.70 |
| High price all time | 36.75 |
| Low price all time | 2.45 |
| Return over 1day | 4.98 |
| Return over 1week | -8.65 |
| Return over 1month | 14.45 |
| Return over 1year | 49.52 |
| Return over 3years | 23.59 |
| Return over 5years | 39.01 |
| Volume 1year average | 2078 |
| DMA 50 | 19.25 |
| DMA 200 | 16.26 |
| DMA 50 previous day | 19.27 |
| DMA 200 previous day | 16.23 |
| MACD | 0.13 |
| MACD Signal | 0.82 |